CIZ.L

Cizzle Biotechnology Holdings Plc CIZ.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CIZ.L FUM.L TCF.L CRTX.L N4P.L POLX.L ROQ.L TRX.L FDBK.L NFX.L
6M -2.58 % -78.63 % -4.00 % 21.05 % 51.88 % -57.50 % 12.16 % -76.86 % -36.31 % 129.81 %
YTD -5.63 % -93.87 % -58.86 % 9.52 % 8.49 % -68.05 % -50.60 % -85.56 % -44.80 % 509.00 %
1Y -22.56 % -94.22 % -70.21 % 21.05 % -5.08 % -68.52 % -46.79 % -84.36 % -81.52 % 387.20 %
3Y -4.13 % -95.21 % -95.40 % -95.54 % -81.02 % -99.02 % -72.79 % -83.11 % -89.80 % -14.23 %
5Y -83.89 % -86.71 % -98.36 % -97.07 % -91.37 % -99.34 % -69.26 % -77.48 % -94.83 % -90.18 %
10Y -83.89 % -92.54 % -99.38 % -99.99 % -81.63 % -96.88 % -69.26 % -99.50 % -98.10 % -88.40 %
From the beginning -83.89 % -97.29 % -99.38 % -100.00 % -99.96 % -96.88 % -69.26 % -99.62 % -99.93 % -88.40 %

Dividend

CRISM Therapeutics Corporation

N4 Pharma Plc

Feedback plc